ITI Pharma and Healthcare Fund - Direct - Growth

Equity Scheme by ITI Asset Management Limited

3Y Returns (CAGR)
19.07%
Expense Ratio
0.98%

as of 01/07/2026

AUM
₹17.17 Cr

Qtr End: Mar 26

NAV
₹19.166

as of 17/07/2026

Historical Performance
Investment growth and SIP performance over time.
Performance Metrics
Returns, CAGR, and Volatility.
Period
Returns
CAGR
Volatility
3M13.39%65.30%12.31%
6M15.79%34.08%14.89%
1Y6.76%6.76%13.56%
3Y68.83%19.07%14.25%
5YN/AN/AN/A
Scheme Details
Launch Date
18/10/2021
Fund Age
4.7 years
Minimum Investment
₹5,000
Fund House
ITI Mutual Fund
Category
Equity Scheme
Sub-category
Sectoral/ Thematic (Equity Scheme)

Frequently Asked Questions